Hyperthyroidism is the most common endocrine disorder in older cats. Comparing treatment options — medication, radioiodine, surgery, and dietary management — reveals important differences in welfare outcomes.
The welfare implications of hyperthyroidism treatment choice are substantial. Daily oral medication is effective but stressful for many cats and owners — pill-averse cats experience restraint stress twice daily, and treatment compliance is a significant challenge. Transdermal gel formulations applied to the ear reduce stress compared to pilling but are slightly less reliable. Radioiodine therapy involves a single hospital stay of seven to fourteen days in isolation — this period of social and environmental deprivation must be weighed against the permanent cure and elimination of lifelong medication burden. Dietary management is stress-free but completely fails if the cat accesses any other food source, making it unsuitable for multi-cat households or outdoor cats. Untreated hyperthyroidism causes progressive cardiac disease, hypertension, and weight loss — significant ongoing suffering. Early diagnosis and committed treatment provide the best long-term welfare outcome.